Canonic Ltd., ya mai da hankali kan haɓaka samfuran cannabis na magani da reshen Evogene Ltd. (Nasdaq: EVGN, TASE: EVGN), ya sanar da ƙaddamar da shi sabon layin samfur a Isra'ila.
Sabon samfur na farko daga layin samfur na ƙarni na biyu ana tsammanin samuwa ga marasa lafiya a farkon Oktoba 2022. Isra'ila na ɗaya daga cikin ƙasashen da ke kan gaba idan aka zo ga sabbin abubuwan da suka faru kayayyakin cannabis na magani.
Babban abun ciki na THC da alamomin kwayoyin halitta
Kayayyakin ƙarni na biyu na Canonic suna da babban abun ciki na THC da bayanan martaba na terpene na musamman. THC shine babban kayan aikin psychoactive a cikin cannabis. Terpenes sune mahadi na shuka da aka sani suna da ƙarin fa'idodin magani, gami da maganin kumburi, analgesia, anxiolytic, antidepressant, anti-rashin bacci, da ƙari. Suna kuma shafar ƙamshi da ƙamshin wiwi.
An haɓaka sabbin samfuran ta hanyar shirye-shiryen kiwo da Canonic ya gudanar a cikin shekaru biyu da suka gabata. Sun haɗa da amfani da saitin mallakar sabbin alamomin kwayoyin halitta. Yin amfani da alamomin kwayoyin halitta yana jagora da hanzarta aiwatar da kiwo don cimma layukan cannabis na musamman waɗanda suka dace da buƙatun kasuwa.
Arnon Heyman, Babban Jami'in Canonic: "Mun sami damar haɓaka yawan cannabinoid da terpene, waɗanda aka sani suna sauƙaƙe alamun da yawa. Wannan ya yiwu ta amfani da fasahar komputa na ci gaba, tare da saiti na almara na alamomi da sauran hanyoyin kiwo masu tasowa. "
Source: canonicbio.com (En)